Clinical Trials
- Heart/Cardiovascular
Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial
- Ages18 years - 95 years
- GenderBoth
- Heart/Cardiovascular
Double blind randomized autologous stem cell trial treatment for peripheral arterial disease (PAD) with critical limb threatening ischemia
- Ages18 years and older
- GenderBoth
- Aging, Heart/Cardiovascular, Brain, Spinal Cord & Nervous System
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults (PREVENTABLE)
- Ages75 years and older
- GenderBoth